Zinc status and risk of cardiovascular diseases and type 2 diabetes mellitus—A systematic review of prospective cohort studies

Nutrients

Volumn 8, Issue 11, 2016, Pages

  Chu, Anna ^a   Foster, Meika ^a   Samman, Samir ^a,b  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Cardiovascular diseases; Diabetes; Epidemiology; Zinc

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ZINC;

ATOMIC ABSORPTION SPECTROMETRY; BIBLIOGRAPHIC DATABASE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CORONARY ANGIOGRAPHY; FOOD FREQUENCY QUESTIONNAIRE; HUMAN; META ANALYSIS (TOPIC); NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; ZINC BLOOD LEVEL; BLOOD; CARDIOVASCULAR DISEASES; COHORT ANALYSIS; DIABETES MELLITUS, TYPE 2; DIET; NUTRITIONAL STATUS; PROSPECTIVE STUDY; RISK FACTOR;

CARDIOVASCULAR DISEASES; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DIET; HUMANS; NUTRITIONAL STATUS; PROSPECTIVE STUDIES; RISK FACTORS; ZINC;

EID: 84995380349     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu8110707     Document Type: Review

References (57)

1. World Health Organisation. Global Status Report On Noncommunicable Diseases 2014; World Health Organisation: Geneva, Switzerland, 2014.
2. Eckel, R.H.; Jakicic, J.M.; Ard, J.D.; de Jesus, J.M.; Houston Miller, N.; Hubbard, V.S.; Lee, I.M.; Lichtenstein, A.H.; Loria, C.M.; Millen, B.E.; et al. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: A report of the American College of cardiology/American Heart Association task force on practice guidelines. Circulation 2014, 129, 76–99. [CrossRef]
3. American Diabetes Association. Standards of Medical Care in Diabetes. Diabetes Care 2015, 38, S1–S93.
4. Samman, S. Zinc. Nutr. Diet. 2007, 64, S131–S134. [CrossRef]
5. Foster, M.; Samman, S. Zinc and redox signaling: perturbations associated with cardiovascular disease and diabetes mellitus. Antioxid. Redox Signal. 2010, 13, 1549–1573. [CrossRef]
6. Haase, H.; Rink, L. Multiple impacts of zinc on immune function. Metallomics 2014, 6, 1175–1180. [CrossRef]
7. Rosenkranz, E.; Maywald, M.; Hilgers, R.D.; Brieger, A.; Clarner, T.; Kipp, M.; Plümäkers, B.; Meyer, S.; Schwerdtle, T.; Rink, L. Induction of regulatory T cells in Th1-/Th17-driven experimental autoimmune encephalomyelitis by zinc administration. J. Nutr. Biochem. 2016, 29, 116–123. [CrossRef]
8. Knip, M.; Siljander, H. Autoimmune mechanisms in type 1 diabetes. Autoimmun. Rev. 2008, 7, 550–557. [CrossRef]
9. McCarthy, M.I. Genomics, type 2 diabetes, and obesity. N. Engl. J. Med. 2010, 363, 2339–2350.
10. Capdor, J.; Foster, M.; Petocz, P.; Samman, S. Zinc and glycemic control: A meta-analysis of randomised placebo controlled supplementation trials in humans. J. Trace Elem. Med. Biol. 2013, 27, 137–142. [CrossRef]
11. Foster, M.; Petocz, P.; Samman, S. Effects of zinc on plasma lipoprotein cholesterol concentrations in humans: A meta-analysis of randomised controlled trials. Atherosclerosis 2010, 210, 344–352. [CrossRef]
12. Little, P.J.; Bhattacharya, R.; Moreyra, A.E.; Korichneva, I.L. Zinc and cardiovascular disease. Nutrition 2010, 26, 1050–1057. [CrossRef]
13. Cortese-Krott, M.M.; Kulakov, L.; Opländer, C.; Kolb-Bachofen, V.; Kröncke, K.-D.; Suschek, C.V. Zinc regulates iNOS-derived nitric oxide formation in endothelial cells. Redox Biol. 2014, 2, 945–954. [CrossRef]
14. Jenner, A.; Ren, M.; Rajendran, R.; Ning, P.; Huat, B.T.K.; Watt, F.; Halliwell, B. Zinc supplementation inhibits lipid peroxidation and the development of atherosclerosis in rabbits fed a high cholesterol diet. Free Radic. Biol. Med. 2007, 42, 559–566. [CrossRef]
15. Bao, B.; Prasad, A. Zinc decreases C-reactive protein, lipid peroxidation, and inflammatory cytokines in elderly subjects: a potential implication of zinc as an atheroprotective agent. Am. J. Clin. Nutr. 2010, 91, 1634–1641. [CrossRef]
16. Beattie, J.H.; Kwun, I.-S. Is zinc deficiency a risk factor for atherosclerosis? Br. J. Nutr. 2004, 91, 177–181. [CrossRef]
17. Reunanen, A.; Knekt, P.; Marniemi, J.; Mäki, J.; Maatela, J.; Aromaa, A. Serum calcium, magnesium, copper and zinc and risk of cardiovascular death. Eur. J. Clin. Nutr. 1996, 50, 431–437.
18. Singh, R.B.; Niaz, M.A.; Rastogi, S.S.; Bajaj, S.; Gaoli, Z.; Shoumin, Z. Current zinc intake and risk of diabetes and coronary artery disease and factors associated with insulin resistance in rural and urban populations of North India. J. Am. Coll. Nutr. 1998, 17, 564–570. [CrossRef]
19. Liberati, A.; Altman, D.G.; Tetzlaff, J.; Mulrow, C.; Gøtzsche, P.C.; Ioannidis, J.P.A.; Clarke, M.; Devereaux, P.J.; Kleijnen, J.; Moher, D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. PLoS Med. 2009, 6, e1000100. [CrossRef]
20. World Health Organization. International Classification of Diseases (ICD-10); World Health Organization: Geneva, Switzerland, 2010.
21. Guyatt, G.H.; Oxman, A.D.; Vist, G.; Kunz, R.; Brozek, J.; Alonso-Coello, P.; Montori, V.; Akl, E.A.; Djulbegovic, B.; Falck-Ytter, Y. GRADE guidelines: 4. Rating the quality of evidence—Study limitations (risk of bias). J. Clin. Epidemiol. 2011, 64, 407–415. [CrossRef]
22. Review Manager (RevMan), version 5.3; The Nordic Cochrane Centre, The Cochrane Collaboration: Copenhagen, Demark, 2014.
23. Soinio, M.; Marniemi, J.; Laakso, M.; Pyörälä, K.; Lehto, S.; Rönnemaa, T. Serum zinc level and coronary heart disease events in patients with type 2 diabetes. Diabetes Care 2007, 30, 523–528. [CrossRef]
24. Al-Delaimy, W.K.; Rimm, E.B.; Willett, W.C.; Stampfer, M.J.; Hu, F.B. Magnesium intake and risk of coronary heart disease among men. J. Am. Coll. Nutr. 2004, 23, 63–70. [CrossRef]
25. Bates, C.J.; Hamer, M.; Mishra, G.D. Redox-modulatory vitamins and minerals that prospectively predict mortality in older British people: The National Diet and Nutrition Survey of people aged 65 years and over. Br. J. Nutr. 2011, 105, 123–132. [CrossRef]
26. Lee, D.-H.; Folsom, A.R.; Jacobs, D.R. Iron, zinc, and alcohol consumption and mortality from cardiovascular diseases: the IowaWomen’s Health Study. Am. J. Clin. Nutr. 2005, 81, 787–791.
27. Leone, N.; Courbon, D.; Ducimetiere, P.; Zureik, M. Zinc, copper, and magnesium and risks for all-cause, cancer, and cardiovascular mortality. Epidemiology 2006, 17, 308–314. [CrossRef]
28. Marniemi, J.; Järvisalo, J.; Toikka, T.; Räihä, I.; Ahotupa, M.; Sourander, L. Blood vitamins, mineral elements and inflammation markers as risk factors of vascular and non-vascular disease mortality in an elderly population. Int. J. Epidemiol. 1998, 27, 799–807. [CrossRef]
29. Mursu, J.; Robien, K.; Harnack, L.J.; Park, K.; Jacobs, D.R., Jr. Dietary supplements and mortality rate in older women. Arch. Intern. Med. 2011, 171, 1625–1633. [CrossRef]
30. Otto, M.C.D.O.; Alonso, A.; Lee, D.; Delclos, G.L.; Bertoni, A.G.; Jiang, R.; Lima, J.A.; Symanski, E.; Jacobs, D.R., Jr.; Nettleton, J.A. Dietary intakes of zinc and heme iron from red meat, but not from other sources, are associated with greater risk of metabolic syndrome and cardiovascular disease. J. Nutr. 2012, 142, 526–533. [CrossRef]
31. Pilz, S.; Dobnig, H.; Winklhofer-Roob, B.M.; Renner, W.; Seelhorst, U.; Wellnitz, B.; Boehm, B.O.; März, W. Low serum zinc concentrations predict mortality in patients referred to coronary angiography. Br. J. Nutr. 2009, 101, 1534–1540. [CrossRef]
32. Vashum, K.P.; McEvoy, M.; Shi, Z.; Milton, A.H.; Islam, M.R.; Sibbritt, D.; Patterson, A.; Byles, J.; Loxton, D.; Attia, J. Is dietary zinc protective for type 2 diabetes? Results from the Australian longitudinal study on women’s health. BMC Endocr. Disord. 2013, 13, 40. [CrossRef]
33. Park, J.S.; Xun, P.; Li, J.; Morris, S.J.; Jacobs, D.R.; Liu, K.; He, K. Longitudinal association between toenail zinc levels and the incidence of diabetes among American young adults: The CARDIA Trace Element Study. Sci. Rep. 2016, 6. [CrossRef]
34. Sun, Q.; van Dam, R.M.; Willett, W.C.; Hu, F.B. Prospective study of zinc intake and risk of type 2 diabetes in women. Diabetes Care 2009, 32, 629–634. [CrossRef]
35. Song, Y.; Xu, Q.; Park, Y.; Hollenbeck, A.; Schatzkin, A.; Chen, H. Multivitamins, individual vitamin and mineral supplements, and risk of diabetes among older U.S. adults. Diabetes Care 2011, 34, 108–114. [CrossRef]
36. Yary, T.; Virtanen, J.K.; Ruusunen, A.; Tuomainen, T.-P.; Voutilainen, S. Serum zinc and risk of type 2 diabetes incidence in men: The Kuopio Ischaemic Heart Disease Risk Factor study. J. Trace Elem. Med. Biol. 2016, 33, 120–124. [CrossRef]
37. Brown, K.H.; Rivera, J.A.; Bhutta, Z.; Gibson, R.S.; King, J.C.; Lönnerdal, B.; Ruel, M.T.; Sandtröm, B.; Wasantwisut, E.; Hotz, C.; et al. International Zinc Nutrition Consultative Group (IZiNCG) technical document #1. Assessment of the risk of zinc deficiency in populations and options for its control. Food Nutr. Bull. 2004, 25, S94–S203.
38. Ruz, M.; Carrasco, F.; Rojas, P.; Codoceo, J.; Inostroza, J.; Basfi-fer, K.; Valencia, A.; Vásquez, K.; Galgani, J.; Pérez, A.; et al. Zinc as a potential coadjuvant in therapy for type 2 diabetes. Food Nutr. Bull. 2013, 34, 215–221. [CrossRef]
39. Luo, Y.-Y.; Zhao, J.; Han, X.-Y.; Zhou, X.-H.; Wu, J.; Ji, L.-N. Relationship between serum zinc level and microvascular complications in patients with type 2 diabetes. Chin. Med. J. (Engl.) 2015, 128, 3276–3282.
40. Michas, G.; Micha, R.; Zampelas, A. Dietary fats and cardiovascular disease: Putting together the pieces of a complicated puzzle. Atherosclerosis 2014, 234, 320–328. [CrossRef]
41. Mamdani, M.; Sykora, K.; Li, P.; Normand, S.-L.T.; Streiner, D.L.; Austin, P.C.; Rochon, P.A.; Anderson, G.M. Reader’s guide to critical appraisal of cohort studies: 2. Assessing potential for confounding. Br. Med. J. 2005, 330, 960–962. [CrossRef]
42. Normand, S.-L.T.; Sykora, K.; Li, P.; Mamdani, M.; Rochon, P.A.; Anderson, G.M. Readers guide to critical appraisal of cohort studies: 3. Analytical strategies to reduce confounding. BMJ 2005, 330, 1021–1023. [CrossRef]
43. Serra-Majem, L.; Pfrimer, K.; Doreste-Alonso, J.; Ribas-Barba, L.; Sánchez-Villegas, A.; Ortiz-Andrellucchi, A.; Henríquez-Sánchez, P. Dietary assessment methods for intakes of iron, calcium, selenium, zinc and iodine. Br. J. Nutr. 2009, 102, S38–S55. [CrossRef]
44. Beckett, J.M.; Hartley, T.F.; Ball, M.J. Evaluation of the Randox colorimetric serum copper and zinc assays against atomic absorption spectroscopy. Ann. Clin. Biochem. 2009, 46, 322–326. [CrossRef]
45. Ronksley, P.E.; Brien, S.E.; Turner, B.J.; Mukamal, K.J.; Ghali, W.A. Association of alcohol consumption with selected cardiovascular disease outcomes: A systematic review and meta-analysis. Br. Med. J. 2011, 342, d671. [CrossRef]
46. Chu, A.; Foster, M.; Samman, S. Determinants of Zinc Transport in Humans: Zinc Status, Exercise, Inflammation and Chronic Diseases. In Human Health and Nutrition: New Research; Ostojic, S., Ed.; Nova Science: New York, NY, USA, 2015; pp. 17–48.
47. Xi, P.; Liu, R.H. Whole food approach for type 2 diabetes prevention. Mol. Nutr. Food Res. 2016, 60, 1819–1836. [CrossRef]
48. Unnikrishnan, R.; Anjana, R.M.; Mohan, V. Diabetes mellitus and its complications in India. Nat. Rev. Endocrinol. 2016, 12, 357–370. [CrossRef]
49. Valera, P.; Zavattari, P.; Sanna, A.; Pretti, S.; Marcello, A.; Mannu, C.; Targhetta, C.; Bruno, G.; Songini, M. Zinc and other metals deficiencies and risk of type 1 diabetes: An ecological study in the high risk Sardinia Island. PLoS ONE 2015, 10, 1–15. [CrossRef]
50. Valera, P.; Zavattari, P.; Albanese, S.; Cicchella, D.; Dinelli, E.; Lima, A.; de Vivo, B. A correlation study between multiple sclerosis and type 1 diabetes incidences and geochemical data in Europe. Environ. Geochem. Health 2014, 36, 79–98. [CrossRef]
51. Lowe, N.M.; Medina, M.W.; Stammers, A.-L.; Patel, S.; Souverein, O.W.; Dullemeijer, C.; Serra-Majem, L.; Nissensohn, M.; Moran, V.H. The relationship between zinc intake and serum/plasma zinc concentration in adults: a systematic review and dose-response meta-analysis by the EURRECA network. Br. J. Nutr. 2012, 108, 1962–1971. [CrossRef]
52. Sandström, B. Bioavailability of zinc. Eur. J. Clin. Nutr. 1997, 51, S17–S19.
53. Foster, M.; Samman, S. Vegetarian Diets Across the Lifecycle: Impact on Zinc Intake and Status. Adv. Food Nutr. Res. 2015, 74, 93–131.
54. Evert, A.B.; Boucher, J.L.; Cypress, M.; Dunbar, S.A.; Franz, M.J.; Mayer-Davis, E.J.; Neumiller, J.J.; Nwankwo, R.; Verdi, C.L.; Urbanski, P.; et al. Nutrition therapy recommendations for the management of adults with diabetes. Diabetes Care 2014, 37, 120–143. [CrossRef]
55. Sandstead, H.H.; Freeland-Graves, J.H. Dietary phytate, zinc and hidden zinc deficiency. J. Trace Elem. Med. Biol. 2014, 28, 414–417. [CrossRef]
56. Chu, A.; Petocz, P.; Samman, S. Immediate effects of aerobic exercise on plasma/serum zinc levels: A meta-analysis. Med. Sci. Sports Exerc. 2016, 48, 726–733. [CrossRef]
57. Hawley, J.A.; Burke, L.M.; Phillips, S.M.; Spriet, L.L. Nutritional modulation of training-induced skeletal muscle adaptations. J. Appl. Physiol. 1985, 110, 834–845. [CrossRef]